BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
903711	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cc(ccc12)N(CC(=O)N1C[C@H](F)C[C@H]1C(=O)NCc1cccc(Cl)c1F)S(C)(=O)=O	InChI=1S/C39H38Cl2F4N6O7S/c1-21(52)28-18-48(19-34(53)49-16-24(42)11-32(49)38(55)46-14-22-5-3-7-29(40)36(22)44)31-13-26(9-10-27(28)31)51(59(2,57)58)20-35(54)50-17-25(43)12-33(50)39(56)47-15-23-6-4-8-30(41)37(23)45/h3-10,13,18,24-25,32-33H,11-12,14-17,19-20H2,1-2H3,(H,46,55)(H,47,56)/t24-,25-,32+,33+/m1/s1	ITRSBQLGALZVHQ-DLKXRSBVSA-N	302863	(2S,4R)-1-(2-(N-(3- acetyl-1-(2-((2S,4R)- 2-(3-chloro-2- fluorobenzyl- carbamoyl)- 4-fluoropyrrolidin- 1-yl)-2-oxoethyl)-1H- indol-6- yl)methylsulfonamido) acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 1::US9598446, Compound 1	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302863	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302863&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118335795	381751598							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903712	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cc(NS(=O)(=O)C(F)(F)F)ccc12	InChI=1S/C25H22ClF5N4O5S/c1-13(36)18-11-34(20-8-16(5-6-17(18)20)33-41(39,40)25(29,30)31)12-22(37)35-10-15(27)7-21(35)24(38)32-9-14-3-2-4-19(26)23(14)28/h2-6,8,11,15,21,33H,7,9-10,12H2,1H3,(H,32,38)/t15-,21+/m1/s1	SQTJLNWMLDJDNK-VFNWGFHPSA-N	302867	(2S,4R)-1-(2-(3- acetyl-6- (trifluoromethylsulfon- amido)-1H-indol-1- yl)acetyl)-N-(3- chloro-2- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 2::US9598446, Compound 2	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302867	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302867&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			91844727	381751602							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903713	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C33H27ClF2N6O3/c1-19(43)26-16-41(29-10-9-21(12-25(26)29)39-22-13-37-18-38-14-22)17-31(44)42-15-20(35)11-30(42)33(45)40-28-8-4-6-24(32(28)36)23-5-2-3-7-27(23)34/h2-10,12-14,16,18,20,30,39H,11,15,17H2,1H3,(H,40,45)/t20-,30+/m1/s1	RKJKLXSEXCNGRV-KEEVHDRGSA-N	302872	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 3::US9598446, Compound 3	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302872	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302872&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322544	381751607							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903714	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H23BrFN7O3/c1-15(36)20-12-34(21-6-5-17(8-19(20)21)31-18-9-29-14-30-10-18)13-25(37)35-11-16(28)7-22(35)26(38)33-24-4-2-3-23(27)32-24/h2-6,8-10,12,14,16,22,31H,7,11,13H2,1H3,(H,32,33,38)/t16-,22+/m1/s1	HMMRVXSBYXZXKG-ZHRRBRCNSA-N	302874	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 6::US9598446, Compound 4	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302874&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322556	381751609							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903715	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncc(F)c3)cc12	InChI=1S/C27H23BrF2N6O3/c1-15(37)21-13-35(22-6-5-18(9-20(21)22)32-19-7-16(29)10-31-11-19)14-26(38)36-12-17(30)8-23(36)27(39)34-25-4-2-3-24(28)33-25/h2-7,9-11,13,17,23,32H,8,12,14H2,1H3,(H,33,34,39)/t17-,23+/m1/s1	AFQUAFCJWNUTTL-HXOBKFHXSA-N	302878	(2S,4R)-1-(2-(3- acetyl-5-(5- fluoropyridin-3- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 5::US9598446, Compound 5	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302878	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302878&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322549	381751613							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903716	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H23BrFN7O3/c1-15(36)20-12-34(21-6-5-17(8-19(20)21)31-18-9-29-14-30-10-18)13-25(37)35-11-16(28)7-22(35)26(38)33-24-4-2-3-23(27)32-24/h2-6,8-10,12,14,16,22,31H,7,11,13H2,1H3,(H,32,33,38)/t16-,22+/m1/s1	HMMRVXSBYXZXKG-ZHRRBRCNSA-N	302874	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 6::US9598446, Compound 4	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302874	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302874&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322556	381751609							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903717	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H](CO)c2cccc(Cl)c2F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H27ClF2N6O4/c1-16(40)22-12-37(25-6-5-18(8-21(22)25)35-19-9-33-15-34-10-19)13-27(41)38-11-17(31)7-26(38)29(42)36-24(14-39)20-3-2-4-23(30)28(20)32/h2-6,8-10,12,15,17,24,26,35,39H,7,11,13-14H2,1H3,(H,36,42)/t17-,24-,26+/m1/s1	ZYGIDXYHEYEFFB-OQRIRGNISA-N	302880	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-((S)-1- (3-chloro-2- fluorophenyl)-2- hydroxyethyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 7::US9598446, Compound 7	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302880	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302880&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322641	381751615							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903718	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H](CO)c2cccc(Cl)c2F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H27ClF2N6O4/c1-16(40)22-12-37(25-6-5-18(8-21(22)25)35-19-9-33-15-34-10-19)13-27(41)38-11-17(31)7-26(38)29(42)36-24(14-39)20-3-2-4-23(30)28(20)32/h2-6,8-10,12,15,17,24,26,35,39H,7,11,13-14H2,1H3,(H,36,42)/t17-,24+,26+/m1/s1	ZYGIDXYHEYEFFB-JWFGRAFASA-N	302881	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-((R)-1- (3-chloro-2- fluorophenyl)-2- hydroxyethyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 8::US9598446, Compound 8	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302881	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302881&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322508	381751616							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903719	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cccnn3)cc12	InChI=1S/C31H25ClF2N8O3/c32-22-7-2-1-5-19(22)20-6-3-8-23(28(20)34)38-31(45)25-13-17(33)15-41(25)27(43)16-42-24-11-10-18(37-26-9-4-12-36-39-26)14-21(24)29(40-42)30(35)44/h1-12,14,17,25H,13,15-16H2,(H2,35,44)(H,37,39)(H,38,45)/t17-,25+/m1/s1	IXPCCHVYUPSKBE-NSYGIPOTSA-N	302882	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-3- ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 9::US9598446, Compound 9	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302882	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302882&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322584	381751617							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903720	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H25ClF2N8O3/c32-23-6-2-1-4-20(23)21-5-3-7-24(28(21)34)39-31(45)26-10-17(33)14-41(26)27(43)15-42-25-9-8-18(38-19-12-36-16-37-13-19)11-22(25)29(40-42)30(35)44/h1-9,11-13,16-17,26,38H,10,14-15H2,(H2,35,44)(H,39,45)/t17-,26+/m1/s1	KVEHFCYWAHYLOA-QUGAMOGWSA-N	302883	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5- ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 10::US9598446, Compound 10	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302883	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302883&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322510	381751618							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903721	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(Nc3cccnn3)cc12	InChI=1S/C25H22ClFN8O3/c26-20-3-1-4-21(31-20)32-25(38)19-9-14(27)11-35(19)23(36)13-34-12-17(24(28)37)16-10-15(6-7-18(16)34)30-22-5-2-8-29-33-22/h1-8,10,12,14,19H,9,11,13H2,(H2,28,37)(H,30,33)(H,31,32,38)/t14-,19+/m1/s1	VGTUMVYVDCLRFN-KUHUBIRLSA-N	441981	1-(2-((2S,4R)-2- (6-chloropyridin- 2-ylcarbamoyl)-4- fluoropyrrolidin- 1-yl)-2-oxoethyl)- 5-(pyridazin-3- ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 11	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=441981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=441981&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135183188	440705689							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903722	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C24H21ClFN9O3/c25-19-2-1-3-20(31-19)32-24(38)18-6-13(26)10-34(18)21(36)11-35-17-5-4-14(30-15-8-28-12-29-9-15)7-16(17)22(33-35)23(27)37/h1-5,7-9,12-13,18,30H,6,10-11H2,(H2,27,37)(H,31,32,38)/t13-,18+/m1/s1	HYNKZTKMOWBTPY-ACJLOTCBSA-N	302889	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5- ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 12::US9598446, Compound 12	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302889	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302889&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322509	381751624							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903723	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3ncc(cn3)C#N)cc12	InChI=1S/C32H24ClF2N9O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(28(21)35)41-31(47)26-10-18(34)15-43(26)27(45)16-44-25-9-8-19(11-22(25)29(42-44)30(37)46)40-32-38-13-17(12-36)14-39-32/h1-9,11,13-14,18,26H,10,15-16H2,(H2,37,46)(H,41,47)(H,38,39,40)/t18-,26+/m1/s1	MUAYRPVDPJBKCK-DWXRJYCRSA-N	302893	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(5- cyanopyrimidin-2- ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 13::US9598446, Compound 13	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302893	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302893&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322516	381751628							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903724	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(Nc3cnc(nc3)C(F)(F)F)cc12	InChI=1S/C32H24ClF5N8O3/c33-22-6-2-1-4-19(22)20-5-3-7-23(27(20)35)43-30(49)25-10-16(34)14-45(25)26(47)15-46-24-9-8-17(11-21(24)28(44-46)29(39)48)42-18-12-40-31(41-13-18)32(36,37)38/h1-9,11-13,16,25,42H,10,14-15H2,(H2,39,48)(H,43,49)/t16-,25+/m1/s1	XXYOBMWPJFTCBD-CPJLOUKISA-N	302900	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- (trifluoromethyl) pyrimidin- 5-ylamino)-1H- indazole-3- carboxamide::US10660876, Cmpd No. 14::US9598446, Compound 14	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302900	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302900&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322539	381751635							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903725	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N(COC(=O)C(C)(C)C)c1cncnc1	InChI=1S/C39H37ClF2N6O5/c1-23(49)30-19-46(33-13-12-25(15-29(30)33)48(26-16-43-21-44-17-26)22-53-38(52)39(2,3)4)20-35(50)47-18-24(41)14-34(47)37(51)45-32-11-7-9-28(36(32)42)27-8-5-6-10-31(27)40/h5-13,15-17,19,21,24,34H,14,18,20,22H2,1-4H3,(H,45,51)/t24-,34+/m1/s1	GNZMPALPIWBMBP-ZWVRTZEQSA-N	302902	((3-acetyl-1-(2- ((2S,4R)-2-(2'-chloro- 2-fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-1H-indol- 5-yl)(pyrimidin-5- yl)amino)methylpivalate::US10660876, Cmpd No. 15::US9598446, Compound 15	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302902	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302902&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322559	381751637							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903726	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H26FN7O3S/c1-17(38)22-14-36(24-7-6-19(9-21(22)24)34-20-10-31-16-32-11-20)15-28(39)37-13-18(30)8-25(37)29(40)33-12-27-35-23-4-2-3-5-26(23)41-27/h2-7,9-11,14,16,18,25,34H,8,12-13,15H2,1H3,(H,33,40)/t18-,25+/m1/s1	SOYGBVIMKRVTTR-CJAUYULYSA-N	302903	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol- yl)acetyl)-N- (benzo[d]thiazol-2- ylmethyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 16::US9598446, Compound 16	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302903	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302903&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322541	381751638							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903727	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-6-5-19(9-22(23)24)33-21-10-29-16-30-11-21)15-26(37)35-13-18(28)8-25(35)27(38)32-12-20-4-2-3-7-31-20/h2-7,9-11,14,16,18,25,33H,8,12-13,15H2,1H3,(H,32,38)/t18-,25+/m1/s1	YDUVJFMYAWLJIK-CJAUYULYSA-N	302928	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-2- ylmethyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 17::US9598446, Compound 17	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302928	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302928&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322646	381751663							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903728	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H25ClF2N6O3/c1-16(38)24-13-36(25-3-2-21(8-23(24)25)35-22-10-32-15-33-11-22)14-27(39)37-12-20(31)7-26(37)28(40)34-9-17-4-18(29)6-19(30)5-17/h2-6,8,10-11,13,15,20,26,35H,7,9,12,14H2,1H3,(H,34,40)/t20-,26+/m1/s1	WVOBBOGINQAHSV-IBVKSMDESA-N	302930	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chloro-5- fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 18::US9598446, Compound 18	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302930&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322582	381751665							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903729	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H26ClFN6O3/c1-17(37)24-14-35(25-6-5-21(9-23(24)25)34-22-11-31-16-32-12-22)15-27(38)36-13-20(30)8-26(36)28(39)33-10-18-3-2-4-19(29)7-18/h2-7,9,11-12,14,16,20,26,34H,8,10,13,15H2,1H3,(H,33,39)/t20-,26+/m1/s1	YYNKXNFVLQYOKI-IBVKSMDESA-N	302931	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chlorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 19::US9598446, Compound 19	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302931&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322553	381751666							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903730	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12	InChI=1S/C22H23FN6O3/c1-13(30)18-10-28(11-21(31)29-9-14(23)5-20(29)22(32)24-2)19-4-3-15(6-17(18)19)27-16-7-25-12-26-8-16/h3-4,6-8,10,12,14,20,27H,5,9,11H2,1-2H3,(H,24,32)/t14-,20+/m1/s1	LKCHOVQRWROKNT-VLIAUNLRSA-N	302945	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- methylpyrrolidine-2- carboxamide::US10660876, Cmpd No. 20::US9598446, Compound 20	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302945&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322557	381751680							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903731	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H23BrFN7O3/c1-15(36)22-12-34(23-3-2-18(6-21(22)23)32-20-9-30-14-31-10-20)13-25(37)35-11-17(28)5-24(35)26(38)33-19-4-16(27)7-29-8-19/h2-4,6-10,12,14,17,24,32H,5,11,13H2,1H3,(H,33,38)/t17-,24+/m1/s1	KCCSOWPTTFVCBI-OSPHWJPCSA-N	303009	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- bromopyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 21::US9598446, Compound 21	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303009&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322562	381751744							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903732	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H23ClFN7O3/c1-15(36)22-12-34(23-3-2-18(6-21(22)23)32-20-9-30-14-31-10-20)13-25(37)35-11-17(28)5-24(35)26(38)33-19-4-16(27)7-29-8-19/h2-4,6-10,12,14,17,24,32H,5,11,13H2,1H3,(H,33,38)/t17-,24+/m1/s1	HBJCDWDKJMRYCW-OSPHWJPCSA-N	303010	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- chloropyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 22::US9598446, Compound 22	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303010&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322555	381751745							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903733	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(Nc5cncnc5)ccc34)cc2C1=O	InChI=1S/C31H30FN7O4/c1-3-37-13-19-4-5-22(9-24(19)31(37)43)36-30(42)28-8-20(32)14-39(28)29(41)16-38-15-26(18(2)40)25-10-21(6-7-27(25)38)35-23-11-33-17-34-12-23/h4-7,9-12,15,17,20,28,35H,3,8,13-14,16H2,1-2H3,(H,36,42)/t20-,28+/m1/s1	ATPSKHFIIPPEIS-NGOKVRLYSA-N	303011	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2-ethyl- 3-oxoisoindolin-5-yl)- 4-fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 23::US9598446, Compound 23	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303011&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322637	381751746							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903734	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CC(C)(C)Oc23)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H31FN6O4/c1-18(39)24-15-37(26-8-7-21(10-23(24)26)35-22-12-33-17-34-13-22)16-28(40)38-14-20(32)9-27(38)30(41)36-25-6-4-5-19-11-31(2,3)42-29(19)25/h4-8,10,12-13,15,17,20,27,35H,9,11,14,16H2,1-3H3,(H,36,41)/t20-,27+/m1/s1	WZHHICLBIJGXRJ-HRFSGMKKSA-N	303012	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2,2- dimethyl-2,3- dihydrobenzofuran-7- yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 24::US9598446, Compound 24	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303012&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322573	381751747							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903735	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(Nc3cncnc3)cc12			303013	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1H-indazol-6- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 25::US9598446, Compound 25	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303013&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322554	381751748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903736	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(Nc3cncnc3)cc12	InChI=1S/C34H33F2N9O3/c1-20(46)27-17-43(29-9-7-22(12-25(27)29)39-24-14-37-19-38-15-24)18-32(47)45-16-21(35)11-30(45)34(48)40-23-6-8-28(36)26(13-23)33-42-41-31-5-3-2-4-10-44(31)33/h6-9,12-15,17,19,21,30,39H,2-5,10-11,16,18H2,1H3,(H,40,48)/t21-,30+/m1/s1	UFEWSPZTKCPRSJ-DFXYEROKSA-N	303015	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-fluoro-3-(6,7,8,9- tetrahydro-5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 26::US9598446, Compound 26	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303015&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322545	381751750							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903737	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CN(Cc23)c2ccccn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C34H31FN8O3/c1-21(44)27-17-41(30-9-8-24(12-26(27)30)39-25-13-36-20-37-14-25)19-33(45)43-16-23(35)11-31(43)34(46)40-29-6-4-5-22-15-42(18-28(22)29)32-7-2-3-10-38-32/h2-10,12-14,17,20,23,31,39H,11,15-16,18-19H2,1H3,(H,40,46)/t23-,31+/m1/s1	WLVKHTJYPXLBSC-IPBJYNAHSA-N	442000	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(2- (pyridin-2- yl)isoindolin-4- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 27	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=442000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=442000&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322576	440705705							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903738	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C34H31F2N7O3S/c1-19(44)26-16-42(29-10-9-23(12-25(26)29)39-24-13-37-18-38-14-24)17-31(45)43-15-22(36)11-30(43)33(46)40-27-3-2-4-28-32(27)47-34(41-28)20-5-7-21(35)8-6-20/h5-10,12-14,16,18,22,27,30,39H,2-4,11,15,17H2,1H3,(H,40,46)/t22-,27?,30+/m1/s1	VZFSQLHHDAVXMK-YHRVPXSNSA-N	303023	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(4-fluorophenyl)- 4,5,6,7- tetrahydrobenzo[d] thiazol- 7-yl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 28::US9598446, Compound 28	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303023&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322629	381751758							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903739	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H24ClFN8O3S/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)28(42)36-29-35-27(37-43-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,36,37,42)/t17-,25+/m1/s1	TVYTXIFEGGLDBX-NSYGIPOTSA-N	303024	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(2- chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 29::US9598446, Compound 29	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303024&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322535	381751759							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903740	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-n2nccc2C)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H29FN8O3/c1-19-9-10-35-40(19)28-6-4-3-5-26(28)37-31(43)29-11-21(32)15-39(29)30(42)17-38-16-25(20(2)41)24-12-22(7-8-27(24)38)36-23-13-33-18-34-14-23/h3-10,12-14,16,18,21,29,36H,11,15,17H2,1-2H3,(H,37,43)/t21-,29+/m1/s1	FNXTWAABCNBCFJ-PBBNMVCDSA-N	303025	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(5-methyl-1H- pyrazol-1- yl)phenyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 30::US9598446, Compound 30	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303025&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322507	381751760							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903741	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H24FN7O3/c1-16(35)22-13-33(23-5-4-18(8-21(22)23)31-20-10-29-15-30-11-20)14-25(36)34-12-17(27)7-24(34)26(37)32-19-3-2-6-28-9-19/h2-6,8-11,13,15,17,24,31H,7,12,14H2,1H3,(H,32,37)/t17-,24+/m1/s1	LYFPJRNZTADLAU-OSPHWJPCSA-N	303026	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 31::US9598446, Compound 31	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303026&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322568	381751761							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903742	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C34H28FN7O3S/c1-20(43)26-17-41(29-11-10-22(13-25(26)29)38-23-14-36-19-37-15-23)18-32(44)42-16-21(35)12-30(42)33(45)39-27-7-3-2-6-24(27)34-40-28-8-4-5-9-31(28)46-34/h2-11,13-15,17,19,21,30,38H,12,16,18H2,1H3,(H,39,45)/t21-,30+/m1/s1	MXDAZWOBUOVFGF-DFXYEROKSA-N	303027	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(2- (benzo[d]thiazol-2- yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 32::US9598446, Compound 32	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303027&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322580	381751762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903743	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C25H22ClFN8O3/c1-14(36)19-11-34(20-3-2-16(5-18(19)20)31-17-6-29-13-30-7-17)12-24(37)35-10-15(27)4-21(35)25(38)33-23-9-28-8-22(26)32-23/h2-3,5-9,11,13,15,21,31H,4,10,12H2,1H3,(H,32,33,38)/t15-,21+/m1/s1	BDZIORIMTVSHFW-VFNWGFHPSA-N	303028	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- chloropyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 33::US9598446, Compound 33	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303028&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322560	381751763							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903744	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H24ClFN8O3S/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)27(42)35-29-37-36-28(43-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,37,42)/t17-,25+/m1/s1	AUXLDALGRIJXBH-NSYGIPOTSA-N	303029	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5-(2- chlorophenyl)-1,3,4- thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 34::US9598446, Compound 34	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303029&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322570	381751764							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903745	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H22F4N6O5/c1-14(39)19-11-37(22-3-2-16(5-18(19)22)35-17-8-33-13-34-9-17)12-26(40)38-10-15(29)4-23(38)27(41)36-21-7-25-24(6-20(21)30)42-28(31,32)43-25/h2-3,5-9,11,13,15,23,35H,4,10,12H2,1H3,(H,36,41)/t15-,23+/m1/s1	PEVSBOFMPAVDJO-CMJOXMDJSA-N	303030	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2,2,6- trifluorobenzo[d][1,3] dioxol-5- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 35::US9598446, Compound 35	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303030&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322537	381751765							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903746	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2O)c2ccc(Nc3cncnc3)cc12	InChI=1S/C27H31FN6O4/c1-16(35)21-13-33(23-7-6-18(9-20(21)23)31-19-10-29-15-30-11-19)14-26(37)34-12-17(28)8-24(34)27(38)32-22-4-2-3-5-25(22)36/h6-7,9-11,13,15,17,22,24-25,31,36H,2-5,8,12,14H2,1H3,(H,32,38)/t17-,22+,24+,25+/m1/s1	FQSQPAAVOVUZKG-ZSVIPDLTSA-N	303031	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- ((1S,2S)-2- hydroxycyclohexyl)pyr- rolidine-2-carboxamide::US10660876, Cmpd No. 36::US9598446, Compound 36	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303031&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322585	381751766							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903747	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H25ClFN9O3/c1-17(41)22-12-38(25-6-5-19(8-21(22)25)36-20-9-32-14-33-10-20)13-27(42)39-11-18(31)7-26(39)29(43)37-24-4-2-3-23(30)28(24)40-16-34-15-35-40/h2-6,8-10,12,14-16,18,26,36H,7,11,13H2,1H3,(H,37,43)/t18-,26+/m1/s1	FBLSRJSPKFKYBV-DWXRJYCRSA-N	303032	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3- chloro-2-(1H-1,2,4- triazol-1-yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 37::US9598446, Compound 37	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303032&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322626	381751767							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903748	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3[nH]c(C)c(C)c3c2)c2ccc(Nc3cncnc3)cc12			442802	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- N-(2,3-dimethyl- 1H-indol-5-yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 38	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=442802	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=442802&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322567	440705716							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903749	CC(=O)c1cn(C(=O)CN2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H23Cl2FN8O3S/c1-15(41)21-12-40(24-5-3-18(8-20(21)24)35-19-9-33-14-34-10-19)26(42)13-39-11-17(32)7-25(39)27(43)36-29-38-37-28(44-29)16-2-4-22(30)23(31)6-16/h2-6,8-10,12,14,17,25,35H,7,11,13H2,1H3,(H,36,38,43)/t17-,25+/m1/s1	SMTUMKLDXICUHQ-NSYGIPOTSA-N	303034	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)-2-oxoethyl)-N-(5- (3,4-dichlorophenyl)- 1,3,4-thiadiazol-2-yl)- 4-fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 39::US9598446, Compound 39	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303034&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322566	381751769							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903750	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H28FN7O5/c1-18(39)23-15-36(25-7-6-20(11-22(23)25)34-21-12-32-17-33-13-21)16-28(40)38-14-19(31)10-27(38)29(41)35-24-4-2-3-5-26(24)37-8-9-43-30(37)42/h2-7,11-13,15,17,19,27,34H,8-10,14,16H2,1H3,(H,35,41)/t19-,27+/m1/s1	JHRXGDFDOKCUTP-WINIVTDRSA-N	303035	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(2-oxooxazolidin- 3- yl)phenyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 40::US9598446, Compound 40	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303035&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322533	381751770							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903751	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nc3nc(nn23)C(F)(F)F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H24F4N10O3/c1-14-5-23(42-27(35-14)38-26(39-42)28(30,31)32)37-25(45)22-6-16(29)10-41(22)24(44)12-40-11-20(15(2)43)19-7-17(3-4-21(19)40)36-18-8-33-13-34-9-18/h3-5,7-9,11,13,16,22,36H,6,10,12H2,1-2H3,(H,37,45)/t16-,22+/m1/s1	YADGHFCERYVAGX-ZHRRBRCNSA-N	303036	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 41::US9598446, Compound 41	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303036&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322561	381751771							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903752	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2)c2cnn(C)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H34FN9O3/c1-19(41)26-16-39(27-6-5-21(9-25(26)27)35-23-10-32-18-33-11-23)17-29(42)40-13-20(31)8-28(40)30(43)36-22-4-3-7-38(14-22)24-12-34-37(2)15-24/h5-6,9-12,15-16,18,20,22,28,35H,3-4,7-8,13-14,17H2,1-2H3,(H,36,43)/t20-,22?,28+/m1/s1	MWQHZUNYDRLVBN-YOBMCTMISA-N	303037	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(1-methyl-1H- pyrazol-4- yl)piperidin-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 42::US9598446, Compound 42	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303037&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322511	381751772							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903753	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-5-4-20(8-22(23)24)33-21-11-30-16-31-12-21)15-26(37)35-13-19(28)7-25(35)27(38)32-10-18-3-2-6-29-9-18/h2-6,8-9,11-12,14,16,19,25,33H,7,10,13,15H2,1H3,(H,32,38)/t19-,25+/m1/s1	BFIHQPVUURUCOH-CLOONOSVSA-N	303038	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-3- ylmethyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 43::US9598446, Compound 43	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303038&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322546	381751773							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903754	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C25H22BrFN8O3/c1-14(36)20-11-34(21-3-2-17(5-19(20)21)32-18-8-28-13-29-9-18)12-23(37)35-10-16(27)4-22(35)24(38)33-25-30-6-15(26)7-31-25/h2-3,5-9,11,13,16,22,32H,4,10,12H2,1H3,(H,30,31,33,38)/t16-,22+/m1/s1	ABCAOIQEZPMKEC-ZHRRBRCNSA-N	303039	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- bromopyrimidin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 44::US9598446, Compound 44	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303039&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322550	381751774							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903755	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(OCc3ccccc3)cn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C33H30FN7O4/c1-21(42)28-17-40(29-9-7-24(12-27(28)29)38-25-13-35-20-36-14-25)18-32(43)41-16-23(34)11-30(41)33(44)39-31-10-8-26(15-37-31)45-19-22-5-3-2-4-6-22/h2-10,12-15,17,20,23,30,38H,11,16,18-19H2,1H3,(H,37,39,44)/t23-,30+/m1/s1	XHXIBPYJNOCISF-DJUQAAIZSA-N	303040	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(5- (benzyloxy)pyridin-2- yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 45::US9598446, Compound 45	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303040&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322648	381751775							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903756	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H27FN6O3/c1-19(39)27-16-37(28-9-8-24(12-26(27)28)35-25-13-33-18-34-14-25)17-30(40)38-15-22(32)11-29(38)31(41)36-23-7-6-20-4-2-3-5-21(20)10-23/h2-10,12-14,16,18,22,29,35H,11,15,17H2,1H3,(H,36,41)/t22-,29+/m1/s1	KLMJCFJJNBKIJW-MNNSJKJDSA-N	303041	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (naphthalen-2- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 46::US9598446, Compound 46	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303041&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322569	381751776							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903757	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C25H22BrFN8O3/c1-14(36)19-11-34(20-3-2-16(5-18(19)20)31-17-6-29-13-30-7-17)12-24(37)35-10-15(27)4-21(35)25(38)33-23-9-28-8-22(26)32-23/h2-3,5-9,11,13,15,21,31H,4,10,12H2,1H3,(H,32,33,38)/t15-,21+/m1/s1	VCVUUNVSBBEWQM-VFNWGFHPSA-N	303042	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(6- bromopyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 47::US9598446, Compound 47	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303042&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322518	381751777							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903758	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2C(F)(F)F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H23ClF4N6O3/c1-15(40)20-12-38(23-6-5-17(8-19(20)23)36-18-9-34-14-35-10-18)13-25(41)39-11-16(30)7-24(39)27(42)37-22-4-2-3-21(29)26(22)28(31,32)33/h2-6,8-10,12,14,16,24,36H,7,11,13H2,1H3,(H,37,42)/t16-,24+/m1/s1	USFCQUHRXUYFMG-GYCJOSAFSA-N	443453	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- N-(3-chloro-2- (trifluoromethyl) phenyl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 48	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443453	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443453&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322577	440705726							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903759	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2c(C)nc3sccn23)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H26FN9O3S2/c1-16-27(39-5-6-44-30(39)34-16)23-14-45-29(36-23)37-28(43)25-7-18(31)11-40(25)26(42)13-38-12-22(17(2)41)21-8-19(3-4-24(21)38)35-20-9-32-15-33-10-20/h3-6,8-10,12,14-15,18,25,35H,7,11,13H2,1-2H3,(H,36,37,43)/t18-,25+/m1/s1	LYDIHGLPZDDVFY-CJAUYULYSA-N	303044	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-(6- methylimidazo[2,1- b]thiazol-5-yl)thiazol- 2-yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 49::US9598446, Compound 49	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303044&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322521	381751779							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903760	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C34H32FN7O3S/c1-20(43)28-16-41(30-9-8-25(12-27(28)30)38-26-13-36-19-37-14-26)17-32(44)42-15-24(35)11-31(42)33(45)40-34-39-29(18-46-34)23-7-6-21-4-2-3-5-22(21)10-23/h6-10,12-14,16,18-19,24,31,38H,2-5,11,15,17H2,1H3,(H,39,40,45)/t24-,31+/m1/s1	BDZNPMGIMUEEPO-XJFCNFDWSA-N	303045	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (4-(5,6,7,8- tetrahydronaphthalen- 2-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 50::US9598446, Compound 50	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303045&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322639	381751780							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903761	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H27F3N6O3/c1-16(40)22-13-38(26-7-2-18(9-21(22)26)36-19-10-34-15-35-11-19)14-28(41)39-12-17(31)8-27(39)30(42)37-25-6-3-20-23(32)4-5-24(33)29(20)25/h2,4-5,7,9-11,13,15,17,25,27,36H,3,6,8,12,14H2,1H3,(H,37,42)/t17-,25?,27+/m1/s1	YHSCFRRYKWOEIC-CLFDNNGGSA-N	303046	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(4,7- difluoro-2,3-dihydro- 1H-inden-1-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 51::US9598446, Compound 51	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303046&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322631	381751781							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903762	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H23F4N7O4/c1-15(41)22-12-39(23-5-3-18(8-21(22)23)36-19-9-34-14-35-10-19)13-26(42)40-11-17(30)7-24(40)28(43)37-27-20-4-2-16(29(31,32)33)6-25(20)44-38-27/h2-6,8-10,12,14,17,24,36H,7,11,13H2,1H3,(H,37,38,43)/t17-,24+/m1/s1	KQRHZJIHVLLZHX-OSPHWJPCSA-N	443457	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(6- (trifluoromethyl) benzo[d]isoxazol-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 52	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443457	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443457&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322650	440705730							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903763	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CN)cc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H28FN7O3/c1-17(37)24-14-35(25-7-6-21(9-23(24)25)33-22-11-31-16-32-12-22)15-27(38)36-13-19(29)8-26(36)28(39)34-20-4-2-18(10-30)3-5-20/h2-7,9,11-12,14,16,19,26,33H,8,10,13,15,30H2,1H3,(H,34,39)/t19-,26+/m1/s1	NJCBKUZEBUKDAT-BCHFMIIMSA-N	303048	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(4- (aminomethyl)phenyl)- 4-fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 53::US9598446, Compound 53	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303048&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322574	381751783							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903764	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12	InChI=1S/C32H33FN6O5/c1-18-8-24-26(6-7-44-31(24)29(9-18)43-3)37-32(42)28-10-20(33)14-39(28)30(41)16-38-15-25(19(2)40)23-11-21(4-5-27(23)38)36-22-12-34-17-35-13-22/h4-5,8-9,11-13,15,17,20,26,28,36H,6-7,10,14,16H2,1-3H3,(H,37,42)/t20-,26?,28+/m1/s1	GFKAGABXEDPLPZ-GVEVBEQQSA-N	303049	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (8-methoxy-6- methylchroman-4- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 54::US9598446, Compound 54	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303049&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322522	381751784							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903765	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H25Cl2FN8O3/c1-16(42)23-13-40(26-5-3-19(8-22(23)26)37-20-9-34-15-35-10-20)14-28(43)41-12-18(33)7-27(41)30(44)38-25-11-36-39-29(25)21-4-2-17(31)6-24(21)32/h2-6,8-11,13,15,18,27,37H,7,12,14H2,1H3,(H,36,39)(H,38,44)/t18-,27+/m1/s1	AOTIYINPRJLNPH-CLYVBNDRSA-N	303050	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(2,4- dichlorophenyl)-1H- pyrazol-4-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 55::US9598446, Compound 55	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303050&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322548	381751785							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903766	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H24FN7O3S/c1-16(37)22-12-35(24-5-3-18(7-21(22)24)33-20-9-30-14-31-10-20)13-27(38)36-11-17(29)6-25(36)28(39)34-19-2-4-23-26(8-19)40-15-32-23/h2-5,7-10,12,14-15,17,25,33H,6,11,13H2,1H3,(H,34,39)/t17-,25+/m1/s1	ZHGHVKKSEKQRFQ-NSYGIPOTSA-N	303051	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N- (benzo[d]thiazol-6- yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 56::US9598446, Compound 56	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303051&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322529	381751786							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903767	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nn2-c2ccccc2F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H28F2N8O3/c1-18-9-29(41(38-18)27-6-4-3-5-25(27)33)37-31(44)28-10-20(32)14-40(28)30(43)16-39-15-24(19(2)42)23-11-21(7-8-26(23)39)36-22-12-34-17-35-13-22/h3-9,11-13,15,17,20,28,36H,10,14,16H2,1-2H3,(H,37,44)/t20-,28+/m1/s1	MGOSREJPXCVOFI-NGOKVRLYSA-N	303052	(2S,4R)-1-(2-(3-  acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(2-fluorophenyl)-3- methyl-1H-pyrazol-5- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 57::US9598446, Compound 57	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303052&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322633	381751787							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903768	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C32H31ClFN7O4/c1-19(42)24-16-39(27-9-8-21(12-23(24)27)37-22-13-35-18-36-14-22)17-30(43)41-15-20(34)11-29(41)31(44)38-26-6-4-10-40(32(26)45)28-7-3-2-5-25(28)33/h2-3,5,7-9,12-14,16,18,20,26,29,37H,4,6,10-11,15,17H2,1H3,(H,38,44)/t20-,26?,29+/m1/s1	UBXVSJSUZAETKL-QHSCGPOWSA-N	303053	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(1-(2- chlorophenyl)-2- oxopiperidin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 58::US9598446, Compound 58	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303053&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322536	381751788							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903769	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C27H26FN7O3/c1-17(36)23-14-34(24-3-2-20(9-22(23)24)33-21-11-30-16-31-12-21)15-26(37)35-13-19(28)8-25(35)27(38)32-10-18-4-6-29-7-5-18/h2-7,9,11-12,14,16,19,25,33H,8,10,13,15H2,1H3,(H,32,38)/t19-,25+/m1/s1	WGMMCCQIKZZOLO-CLOONOSVSA-N	303054	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (pyridin-4- ylmethyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 59::US9598446, Compound 59	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303054&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322634	381751789							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903770	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H24ClFN8O3S/c1-16(40)23-13-38(24-6-5-20(9-22(23)24)34-21-10-32-15-33-11-21)14-26(41)39-12-19(31)8-25(39)28(42)36-29-35-27(37-43-29)17-3-2-4-18(30)7-17/h2-7,9-11,13,15,19,25,34H,8,12,14H2,1H3,(H,35,36,37,42)/t19-,25+/m1/s1	MQJLVLVDTJKBMP-CLOONOSVSA-N	303055	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-N-(3-(3- chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 60::US9598446, Compound 60	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303055&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322524	381751790							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903771	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nncn2C)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H28FN9O3/c1-18(41)24-14-39(26-8-7-20(10-23(24)26)35-21-11-32-16-33-12-21)15-28(42)40-13-19(31)9-27(40)30(43)36-25-6-4-3-5-22(25)29-37-34-17-38(29)2/h3-8,10-12,14,16-17,19,27,35H,9,13,15H2,1-2H3,(H,36,43)/t19-,27+/m1/s1	NQJQOGSCDFXIGA-WINIVTDRSA-N	303056	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (2-(4-methyl-4H- 1,2,4-triazol-3- yl)phenyl)pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 61::US9598446, Compound 61	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303056&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322644	381751791							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903772	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc(n2)-c2ccccc2Cl)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H24ClFN8O4/c1-16(40)22-13-38(24-7-6-18(9-21(22)24)34-19-10-32-15-33-11-19)14-26(41)39-12-17(31)8-25(39)27(42)35-29-36-28(43-37-29)20-4-2-3-5-23(20)30/h2-7,9-11,13,15,17,25,34H,8,12,14H2,1H3,(H,35,37,42)/t17-,25+/m1/s1	YBRRPQXZTADARY-NSYGIPOTSA-N	303057	(2S,4R)-1-(2-(3-  acetyl-5-(pyrimidin-5-  ylamino)-1H-indol-1- yl)acetyl)-N-(5-(2- chlorophenyl)-1,2,4- oxadiazol-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10660876, Cmpd No. 62::US9598446, Compound 62	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303057&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322525	381751792							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903773	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2cc(C)ccc2F)c2ccc(Nc3cncnc3)cc12	InChI=1S/C33H33F2N7O4/c1-19-5-7-26(35)29(10-19)41-9-3-4-27(33(41)46)39-32(45)30-11-21(34)15-42(30)31(44)17-40-16-25(20(2)43)24-12-22(6-8-28(24)40)38-23-13-36-18-37-14-23/h5-8,10,12-14,16,18,21,27,30,38H,3-4,9,11,15,17H2,1-2H3,(H,39,45)/t21-,27?,30+/m1/s1	NCZJJJKTTOBGNN-MNOFBEFESA-N	303058	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(2-fluoro-5- methylphenyl)-2- oxopiperidin-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 63::US9598446, Compound 63	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303058&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322534	381751793							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903774	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCN(C2=O)c2ccn(C)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H30FN9O4/c1-17(40)22-14-37(24-4-3-19(10-21(22)24)33-20-11-31-16-32-12-20)15-27(41)39-13-18(30)9-25(39)28(42)34-23-5-8-38(29(23)43)26-6-7-36(2)35-26/h3-4,6-7,10-12,14,16,18,23,25,33H,5,8-9,13,15H2,1-2H3,(H,34,42)/t18-,23?,25+/m1/s1	CUJFHVUQADDZQW-IJMIUMFMSA-N	303059	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (1-(1-methyl-1H- pyrazol-3-yl)-2- oxopyrrolidin-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 64::US9598446, Compound 64	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303059&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322627	381751794							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903775	CC1CC1c1cc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2cc(C(C)=O)c3cc(Nc4cncnc4)ccc23)on1	InChI=1S/C28H28FN7O4/c1-15-5-20(15)23-8-26(40-34-23)33-28(39)25-6-17(29)11-36(25)27(38)13-35-12-22(16(2)37)21-7-18(3-4-24(21)35)32-19-9-30-14-31-10-19/h3-4,7-10,12,14-15,17,20,25,32H,5-6,11,13H2,1-2H3,(H,33,39)/t15?,17-,20?,25+/m1/s1	ILHCBLRKOZWWJZ-YSLVQCDHSA-N	443470	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(3-(2- methylcyclopropyl) isoxazol-5- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 65	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443470	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443470&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322643	440705743							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903776	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2n[nH]c(C)c2-c2ccccc2)c2ccc(Nc3cncnc3)cc12			443471	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(5- methyl-4-phenyl- 1H-pyrazol-3- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 66	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443471	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443471&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			155802583	440705744							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903777	CC1Cc2c(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(Nc5cncnc5)ccc34)nn(C)c2NC1=O	InChI=1S/C29H30FN9O4/c1-15-6-21-26(36-37(3)27(21)35-28(15)42)34-29(43)24-7-17(30)11-39(24)25(41)13-38-12-22(16(2)40)20-8-18(4-5-23(20)38)33-19-9-31-14-32-10-19/h4-5,8-10,12,14-15,17,24,33H,6-7,11,13H2,1-3H3,(H,35,42)(H,34,36,43)/t15?,17-,24+/m1/s1	DYQCLSWOXIQSES-MYSSZOINSA-N	443472	(2S 4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- N-(1,5-dimethyl- 6-oxo-4,5,6,7- tetrahydro-1H- pyrazolo[3,4- b]pyridin-3-yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 67	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443472	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443472&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			136992756	440705745							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903778	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H24FN7O4/c1-15(35)20-12-33(21-6-5-17(8-19(20)21)30-18-9-28-14-29-10-18)13-25(37)34-11-16(27)7-22(34)26(38)32-23-3-2-4-24(36)31-23/h2-6,8-10,12,14,16,22,30H,7,11,13H2,1H3,(H2,31,32,36,38)/t16-,22+/m1/s1	YWZWNWRNFFGSJH-ZHRRBRCNSA-N	303060	(2S,4R)-1-(2-(3- acetyl-5-(pyrimidin-5- ylamino)-1H-indol-1- yl)acetyl)-4-fluoro-N- (6-hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 68::US9598446, Compound 68	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=303060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=303060&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322575	381751795							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903779	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCC[C@H]2O)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H29FN6O4/c1-15(34)20-12-32(22-6-5-17(8-19(20)22)30-18-9-28-14-29-10-18)13-25(36)33-11-16(27)7-23(33)26(37)31-21-3-2-4-24(21)35/h5-6,8-10,12,14,16,21,23-24,30,35H,2-4,7,11,13H2,1H3,(H,31,37)/t16-,21-,23+,24-/m1/s1	GJLJBCJSBGYTLO-ZOWXDCFTSA-N	443474	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N- ((1R,2R)-2- hydroxy- cyclopentyl) pyrrolidine-2- carboxamide::US10660876, Cmpd No. 69	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443474&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118333559	440705747							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903780	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(O)cn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H24FN7O4/c1-15(35)21-12-33(22-4-2-17(7-20(21)22)31-18-8-28-14-29-9-18)13-25(37)34-11-16(27)6-23(34)26(38)32-24-5-3-19(36)10-30-24/h2-5,7-10,12,14,16,23,31,36H,6,11,13H2,1H3,(H,30,32,38)/t16-,23+/m1/s1	WNQIWEXYELPQQQ-MWTRTKDXSA-N	443475	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(5- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 70	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443475	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443475&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322640	440705748							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903781	CC1Oc2cccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(Nc5cncnc5)ccc34)c2NC1=O	InChI=1S/C30H28FN7O5/c1-16(39)22-13-37(24-7-6-19(9-21(22)24)34-20-10-32-15-33-11-20)14-27(40)38-12-18(31)8-25(38)30(42)35-23-4-3-5-26-28(23)36-29(41)17(2)43-26/h3-7,9-11,13,15,17-18,25,34H,8,12,14H2,1-2H3,(H,35,42)(H,36,41)/t17?,18-,25+/m1/s1	MSSBTSNIUCZFOW-IMVPFUBLSA-N	443476	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(2- methyl-3-oxo-3,4- dihydro-2H- benzo[b][1,4] oxazin-5- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 71	Complement factor D	Human		 5500							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443476	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443476&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322579	440705749							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903782	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(O)ccn2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H24FN7O4/c1-15(35)21-12-33(22-3-2-17(7-20(21)22)31-18-9-28-14-29-10-18)13-25(37)34-11-16(27)6-23(34)26(38)32-24-8-19(36)4-5-30-24/h2-5,7-10,12,14,16,23,31H,6,11,13H2,1H3,(H2,30,32,36,38)/t16-,23+/m1/s1	RRLXRHPOZVERCE-MWTRTKDXSA-N	443477	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-(4- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10660876, Cmpd No. 72	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443477	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443477&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322558	440705750							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903783	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nccc(Cl)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C25H22ClFN8O3/c1-14(36)19-11-34(20-3-2-16(7-18(19)20)31-17-8-28-13-29-9-17)12-23(37)35-10-15(27)6-21(35)24(38)33-25-30-5-4-22(26)32-25/h2-5,7-9,11,13,15,21,31H,6,10,12H2,1H3,(H,30,32,33,38)/t15-,21+/m1/s1	QHOULWIWUDILRP-VFNWGFHPSA-N	443478	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- N-(4- chloropyrimidin- 2-yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 73	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443478	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443478&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322528	440705751							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903784	C[C@@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12)c1oc2ccc(F)cc2c1C	InChI=1S/C32H30F2N6O4/c1-17-24-8-20(33)4-7-29(24)44-31(17)18(2)37-32(43)28-9-21(34)13-40(28)30(42)15-39-14-26(19(3)41)25-10-22(5-6-27(25)39)38-23-11-35-16-36-12-23/h4-8,10-12,14,16,18,21,28,38H,9,13,15H2,1-3H3,(H,37,43)/t18-,21-,28+/m1/s1	ZRPPCASGHVTZNT-XZVJFGJNSA-N	443479	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-((R)-1- (5-fluoro-3- methyl- benzofuran-2- yl)ethyl) pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 74	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443479	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443479&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322547	440705752							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903785	C[C@H](NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(Nc3cncnc3)ccc12)c1oc2ccc(F)cc2c1C	InChI=1S/C32H30F2N6O4/c1-17-24-8-20(33)4-7-29(24)44-31(17)18(2)37-32(43)28-9-21(34)13-40(28)30(42)15-39-14-26(19(3)41)25-10-22(5-6-27(25)39)38-23-11-35-16-36-12-23/h4-8,10-12,14,16,18,21,28,38H,9,13,15H2,1-3H3,(H,37,43)/t18-,21+,28-/m0/s1	ZRPPCASGHVTZNT-LVFJRYOWSA-N	443480	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- 4-fluoro-N-((S)-1- (5-fluoro-3- methylbenzofuran- 2-yl)ethyl) pyrrolidine- 2-carboxamide::US10660876, Cmpd No. 75	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443480	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443480&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118322515	440705753							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903786	COCCOc1ncc(Nc2ccc3n(CC(=O)N4C[C@H](F)C[C@H]4C(=O)Nc4cccc(Br)n4)cc(C(C)=O)c3c2)cn1	InChI=1S/C29H29BrFN7O5/c1-17(39)22-15-37(16-27(40)38-14-18(31)10-24(38)28(41)36-26-5-3-4-25(30)35-26)23-7-6-19(11-21(22)23)34-20-12-32-29(33-13-20)43-9-8-42-2/h3-7,11-13,15,18,24,34H,8-10,14,16H2,1-2H3,(H,35,36,41)/t18-,24+/m1/s1	YGGCEBRHGVZJDJ-KOSHJBKYSA-N	443481	(2S,4R)-1-(2-(3- acetyl-5-(2-(2- methoxyethoxy) pyrimidin-5- ylamino)-1H- indol-1-yl)acetyl)- N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 76	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443481	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443481&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624020	440705754							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903787	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccc2)c2ccc(Nc3cccnc3)cc12	InChI=1S/C29H28FN5O3/c1-19(36)25-17-34(26-10-9-22(13-24(25)26)33-23-8-5-11-31-15-23)18-28(37)35-16-21(30)12-27(35)29(38)32-14-20-6-3-2-4-7-20/h2-11,13,15,17,21,27,33H,12,14,16,18H2,1H3,(H,32,38)/t21-,27+/m1/s1	VBYFFOAMEKJUEP-ZBLYBZFDSA-N	443482	(2S,4R)-1-(2-(3- acetyl-5- (pyridin-3- ylamino)-1H- indol-1- yl)acetyl)-N- benzyl-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 146	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443482	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443482&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624009	440705755							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903788	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCc2ccccc2)c2ccc(Nc3cccnc3)cc12	InChI=1S/C30H30FN5O3/c1-20(37)26-18-35(27-10-9-23(15-25(26)27)34-24-8-5-12-32-16-24)19-29(38)36-17-22(31)14-28(36)30(39)33-13-11-21-6-3-2-4-7-21/h2-10,12,15-16,18,22,28,34H,11,13-14,17,19H2,1H3,(H,33,39)/t22-,28+/m1/s1	PYSBDYYUZRDSBS-DFHRPNOPSA-N	443483	(2S,4R)-1-(2-(3- acetyl-5- (pyridin-3- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N- phenethylpyrrolidin- 2-carboxamide::US10660876, Cmpd No. 148	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443483	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443483&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623998	440705756							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903789	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCc2ccccc2)c2ccc(Nc3cccnc3)cc12	InChI=1S/C31H32FN5O3/c1-21(38)27-19-36(28-12-11-24(16-26(27)28)35-25-10-6-13-33-17-25)20-30(39)37-18-23(32)15-29(37)31(40)34-14-5-9-22-7-3-2-4-8-22/h2-4,6-8,10-13,16-17,19,23,29,35H,5,9,14-15,18,20H2,1H3,(H,34,40)/t23-,29+/m1/s1	CIMHHGOKPKEKPL-BTYSJIOQSA-N	443484	(2S,4R)-1-(2-(3- acetyl-5- (pyridin-3- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N-(3- phenylpropyl) pyrrolidine-2- carboxamide::US10660876, Cmpd No. 150	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443484	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443484&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623838	440705757							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903790	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCc2ccccc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C29H29FN6O3/c1-19(37)25-16-35(26-8-7-22(12-24(25)26)34-23-13-31-18-32-14-23)17-28(38)36-15-21(30)11-27(36)29(39)33-10-9-20-5-3-2-4-6-20/h2-8,12-14,16,18,21,27,34H,9-11,15,17H2,1H3,(H,33,39)/t21-,27+/m1/s1	MDFJQLNXGPBJRJ-ZBLYBZFDSA-N	443485	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N- phenethylpyrrolidin- 2-carboxamide::US10660876, Cmpd No. 154	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443485	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443485&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624012	440705758							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903791	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCc2ccccc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C30H31FN6O3/c1-20(38)26-17-36(27-10-9-23(13-25(26)27)35-24-14-32-19-33-15-24)18-29(39)37-16-22(31)12-28(37)30(40)34-11-5-8-21-6-3-2-4-7-21/h2-4,6-7,9-10,13-15,17,19,22,28,35H,5,8,11-12,16,18H2,1H3,(H,34,40)/t22-,28+/m1/s1	WWFZESVPPZOLRE-DFHRPNOPSA-N	443486	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N-(3- phenylpropyl) pyrrolidine-2- carboxamide::US10660876, Cmpd No. 155	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443486	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443486&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623850	440705759							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903792	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C28H27FN6O3/c1-18(36)24-15-34(25-8-7-21(10-23(24)25)33-22-12-30-17-31-13-22)16-27(37)35-14-20(29)9-26(35)28(38)32-11-19-5-3-2-4-6-19/h2-8,10,12-13,15,17,20,26,33H,9,11,14,16H2,1H3,(H,32,38)/t20-,26+/m1/s1	FPCFAXDKNAKGSI-IBVKSMDESA-N	443487	(2S,4R)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1- yl)acetyl)-N- benzyl-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 153	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443487	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443487&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624127	440705760							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903793	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCCc2ccccc2)c2ccc(Nc3cccnc3)cc12	InChI=1S/C32H34FN5O3/c1-22(39)28-20-37(29-13-12-25(17-27(28)29)36-26-11-7-14-34-18-26)21-31(40)38-19-24(33)16-30(38)32(41)35-15-6-5-10-23-8-3-2-4-9-23/h2-4,7-9,11-14,17-18,20,24,30,36H,5-6,10,15-16,19,21H2,1H3,(H,35,41)/t24-,30+/m1/s1	GAEULYIDYILZEJ-HLADLETHSA-N	443488	(2S,4R)-1-(2-(3- acetyl-5- (pyridin-3- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N-(4- phenylbutyl) pyrrolidine-2- carboxamide::US10660876, Cmpd No. 152	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443488&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623875	440705761							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903794	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCCCCc2ccccc2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C31H33FN6O3/c1-21(39)27-18-37(28-11-10-24(14-26(27)28)36-25-15-33-20-34-16-25)19-30(40)38-17-23(32)13-29(38)31(41)35-12-6-5-9-22-7-3-2-4-8-22/h2-4,7-8,10-11,14-16,18,20,23,29,36H,5-6,9,12-13,17,19H2,1H3,(H,35,41)/t23-,29+/m1/s1	FDBRPALVNZMEJG-BTYSJIOQSA-N	443489	(2S,4R)-1-(2- (3-acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1- yl)acetyl)-4- fluoro-N-(4- phenylbutyl) pyrrolidine-2- carboxamide::US10660876, Cmpd No. 156	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443489	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443489&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623982	440705762							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903795	Cc1cccc(NC(=O)[C@@H]2C3CCC(C3)N2C(=O)Cn2cc(C(N)=O)c3cc(Nc4ccc(Cl)nn4)ccc23)n1	InChI=1S/C28H27ClN8O3/c1-15-3-2-4-23(31-15)33-28(40)26-16-5-7-18(11-16)37(26)25(38)14-36-13-20(27(30)39)19-12-17(6-8-21(19)36)32-24-10-9-22(29)34-35-24/h2-4,6,8-10,12-13,16,18,26H,5,7,11,14H2,1H3,(H2,30,39)(H,32,35)(H,31,33,40)/t16?,18?,26-/m0/s1	XQMAPWRUEWYQRY-ZJLVLRRJSA-N	443490	5-((6- chloropyridazin- 3-yl)amino)-1-(2- ((3S,4R)-3-((6- methylpyridin-2- yl)carbamoyl)-2- azabicyclo[2.2.1] heptan-2-yl)-2- oxoethyl)-1H- indole-3- carboxamide::US10660876, Cmpd No. 162	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443490	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443490&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135182777	440705763							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903796	CC(=O)c1cn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(Nc3cccnc3)cc12	InChI=1S/C27H26N6O3/c1-17-5-3-7-25(29-17)31-27(36)24-10-12-33(24)26(35)16-32-15-22(18(2)34)21-13-19(8-9-23(21)32)30-20-6-4-11-28-14-20/h3-9,11,13-15,24,30H,10,12,16H2,1-2H3,(H,29,31,36)/t24-/m0/s1	RLDVGQVXNMNGCP-DEOSSOPVSA-N	443491	(S)-1-(2-(3- acetyl-5- (pyridin-3- ylamino)-1H- indol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10660876, Cmpd No. 159	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443491	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443491&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624063	440705764							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903797	CC(=O)c1cn(CC(=O)N2CC[C@H]2C(=O)Nc2cccc(C)n2)c2ccc(Nc3cncnc3)cc12	InChI=1S/C26H25N7O3/c1-16-4-3-5-24(29-16)31-26(36)23-8-9-33(23)25(35)14-32-13-21(17(2)34)20-10-18(6-7-22(20)32)30-19-11-27-15-28-12-19/h3-7,10-13,15,23,30H,8-9,14H2,1-2H3,(H,29,31,36)/t23-/m0/s1	MBKQFDQLUYKHDX-QHCPKHFHSA-N	443492	(S)-1-(2-(3- acetyl-5- (pyrimidin-5- ylamino)-1H- indol-1- yl)acetyl)-N-(6- methylpyridin-2- yl)azetidine-2- carboxamide::US10660876, Cmpd No. 160	Complement factor D	Human		>10000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443492	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443492&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623990	440705765							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903798	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cnc(C)nc3)cc12	InChI=1S/C26H24BrFN8O3/c1-14(37)25-19-9-17(31-18-10-29-15(2)30-11-18)6-7-20(19)36(34-25)13-24(38)35-12-16(28)8-21(35)26(39)33-23-5-3-4-22(27)32-23/h3-7,9-11,16,21,31H,8,12-13H2,1-2H3,(H,32,33,39)/t16-,21+/m1/s1	KUKXSPJBEIGCPJ-IERDGZPVSA-N	443493	(2S,4R)-1-(2-(3- acetyl-5-((2- methylpyrimidin- 5-yl)amino)- 1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 163	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443493	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443493&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126623909	440705766							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903799	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(Nc3cncc(F)c3)cc12	InChI=1S/C26H22BrF2N7O3/c1-14(37)25-19-9-17(31-18-7-15(28)10-30-11-18)5-6-20(19)36(34-25)13-24(38)35-12-16(29)8-21(35)26(39)33-23-4-2-3-22(27)32-23/h2-7,9-11,16,21,31H,8,12-13H2,1H3,(H,32,33,39)/t16-,21+/m1/s1	OYPODSNPWUXLIN-IERDGZPVSA-N	443494	(2S,4R)-1-(2-(3- acetyl-5-((5- yl)amino)-1H- indazol-1- yl)acetyl)-N-(6- bromopyridin-2- yl)-4- fluoropyrrolidine- 2-carboxamide::US10660876, Cmpd No. 164	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443494	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443494&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			126624046	440705767							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
903800	CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(Nc3cncc(F)c3)cc12	InChI=1S/C29H27BrFN7O3/c1-15-4-7-24(30)34-27(15)35-28(41)22-10-29(3)11-23(29)38(22)25(40)14-37-21-6-5-18(9-20(21)26(36-37)16(2)39)33-19-8-17(31)12-32-13-19/h4-9,12-13,22-23,33H,10-11,14H2,1-3H3,(H,34,35,41)/t22-,23+,29-/m0/s1	XBRSREHQCYYBNM-CTWZREHQSA-N	443495	(1R,3S,5R)-2-(2- (3-acetyl-5-((5- fluoropyridin-3- yl)amino)-1H- indazol-1- yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide::US10660876, Cmpd No. 165	Complement factor D	Human		<1000							US Patent		10.7270/Q28D0098		aid1804423	US10660876	Wiles, JA; Phadke, AS; Deshpande, M; Agarwal, A; Chen, D; Gadhachanda, VR; Hashimoto, A; Pais, G; Wang, Q; Wang, X	5/26/2020	2/7/2021	Achillion Pharmaceuticals, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=443495	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=443495&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			135146708	440705768							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4